Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

C.H. Polman, L. Kappos, M.S. Freedman, G. Edan, H.P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, K. Selmaj, B.M.J. Uitdehaag, S. Dahms, L. Bauer, C. Pohl, R. Sandbrink

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)480-487
JournalJournal of Neurology
Volume255
Issue number4
DOIs
Publication statusPublished - 2008

Cite this

Polman, C. H., Kappos, L., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., ... Sandbrink, R. (2008). Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. Journal of Neurology, 255(4), 480-487. https://doi.org/10.1007/s00415-007-0733-2